As of the latest SEC filings, Protagonist Therapeutics, Inc (PTGX) is held by 375 institutional funds. The largest fund shareholder is iShares Core S&P Small-Cap ETF (IJR), holding an estimated $371,984,004.00 in market value, representing 0.40% of its portfolio.
Funds holding Protagonist Therapeutics, Inc (PTGX)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- PTGX
- CIK:
- 0001377121
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
IJR
iShares Core S&P Small-Cap ETF
|
ETF | BlackRock / iShares | 0.40% | $371,984,004.00 | 3,529,260 | Mar 31, 2026 | May 26, 2026 |
|
VTI
VANGUARD TOTAL STOCK MARKET INDEX FUND
|
ETF | Vanguard | 0.01% | $214,738,798.00 | 2,037,370 | Mar 31, 2026 | May 28, 2026 |
|
NAESX
VANGUARD SMALL-CAP INDEX FUND
|
ETF | Vanguard | 0.09% | $155,064,480.00 | 1,471,200 | Mar 31, 2026 | May 28, 2026 |
|
IWM
iShares Russell 2000 ETF
|
ETF | BlackRock / iShares | 0.21% | $149,910,947.00 | 1,422,305 | Mar 31, 2026 | May 28, 2026 |
|
VGHAX
VANGUARD HEALTH CARE FUND
|
MF | Vanguard | 0.37% | $136,622,641.65 | 1,380,445 | Apr 30, 2026 | Jun 26, 2026 |
|
PRHSX
T. Rowe Price Health Sciences Fund, Inc.
|
MF | T. Rowe Price | 1.11% | $120,373,018.60 | 1,142,059 | Mar 31, 2026 | May 28, 2026 |
|
XBI
State Street(R) SPDR(R) S&P(R) Biotech ETF
|
ETF | State Street (SPDR) | 1.24% | $92,548,683.40 | 878,071 | Mar 31, 2026 | May 28, 2026 |
|
VISGX
VANGUARD SMALL-CAP GROWTH INDEX FUND
|
ETF | Vanguard | 0.22% | $86,705,307.40 | 822,631 | Mar 31, 2026 | May 28, 2026 |
|
VEMPX
VANGUARD EXTENDED MARKET INDEX FUND
|
ETF | Vanguard | 0.08% | $69,194,362.20 | 656,493 | Mar 31, 2026 | May 28, 2026 |
|
FSSNX
Fidelity Small Cap Index Fund
|
MF | Fidelity | 0.17% | $56,938,727.61 | 575,313 | Apr 30, 2026 | Jun 26, 2026 |
|
SPSM
State Street(R) SPDR(R) Portfolio S&P 600(TM) Small Cap ETF
|
ETF | State Street (SPDR) | 0.40% | $56,098,096.00 | 532,240 | Mar 31, 2026 | May 28, 2026 |
|
JATTX
Janus Henderson Triton Fund
|
MF | Independent / Boutique | 1.03% | $53,611,499.20 | 508,648 | Mar 31, 2026 | May 29, 2026 |
|
IJT
iShares S&P Small-Cap 600 Growth ETF
|
ETF | BlackRock / iShares | 0.82% | $53,438,748.60 | 507,009 | Mar 31, 2026 | May 28, 2026 |
|
IWO
iShares Russell 2000 Growth ETF
|
ETF | BlackRock / iShares | 0.41% | $50,021,996.80 | 474,592 | Mar 31, 2026 | May 28, 2026 |
|
IBB
iShares Biotechnology ETF
|
ETF | BlackRock / iShares | 0.58% | $47,118,753.80 | 447,047 | Mar 31, 2026 | May 28, 2026 |
|
HRSMX
Hood River Small-Cap Growth Fund
|
MF | Independent / Boutique | 0.90% | $46,929,139.20 | 445,248 | Mar 31, 2026 | May 29, 2026 |
|
FBIOX
Select Biotechnology Portfolio
|
MF | Fidelity | 0.87% | $46,658,133.04 | 506,713 | Feb 28, 2026 | Apr 24, 2026 |
|
XSMO
Invesco S&P SmallCap Momentum ETF
|
ETF | Invesco | 1.63% | $44,935,052.19 | 454,027 | Apr 30, 2026 | Jun 26, 2026 |
|
ODINX
Invesco Discovery Fund
|
MF | Invesco | 0.65% | $43,372,442.40 | 471,030 | Feb 28, 2026 | Apr 28, 2026 |
|
VTSIX
VANGUARD TAX-MANAGED SMALL-CAP FUND
|
MF | Vanguard | 0.44% | $42,162,213.40 | 400,021 | Mar 31, 2026 | May 28, 2026 |
|
ANOIX
Small Cap Growth Fund
|
MF | American Century | 0.79% | $40,255,354.71 | 406,743 | Apr 30, 2026 | Jun 26, 2026 |
|
JAVTX
Janus Henderson Venture Fund
|
MF | Independent / Boutique | 1.12% | $34,297,370.80 | 325,402 | Mar 31, 2026 | May 29, 2026 |
|
SHSKX
BlackRock Health Sciences Opportunities Portfolio
|
MF | BlackRock / iShares | 0.52% | $34,107,168.64 | 370,408 | Feb 27, 2026 | Apr 24, 2026 |
|
PGOAX
PGIM Jennison Small Company Fund
|
MF | PGIM / Prudential | 1.04% | $33,097,813.40 | 314,021 | Mar 31, 2026 | May 27, 2026 |
|
VEXPX
VANGUARD EXPLORER FUND
|
MF | Vanguard | 0.15% | $32,917,422.00 | 332,600 | Apr 30, 2026 | Jun 26, 2026 |
Advertisement (320x50)